FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
23,033,476
Share change
+2,693,720
Total reported value
$354,482,689
Price per share
$15.39
Number of holders
109
Value change
+$34,055,152
Number of buys
58
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q3 2015

As of 30 Sep 2015, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,033,476 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP LLC, STATE STREET CORP, GREAT POINT PARTNERS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Versant Venture Management, LLC, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LLC, and VANGUARD GROUP INC. This page lists 109 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.